Browse the full directors' dealings record of Premier, Inc., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Premier, Inc. has recorded 64 public disclosures. Market capitalisation: €2.3bn. The latest transaction was reported on 6 May 2022 — Attribution. Among the most active insiders: Klatsky David L. Every trade is free.
0 of 0 declarations
Premier, Inc. (ticker: PINC) is a United States-based healthcare company that has traded on the NASDAQ, placing it among the NYSE/NASDAQ-listed names followed by equity investors in the U.S. market. Headquartered in Charlotte, North Carolina, Premier describes itself as a technology-driven healthcare improvement company focused on helping providers lower costs, improve outcomes, and strengthen operational performance across the U.S. healthcare system. The company says it supports roughly two-thirds of U.S. healthcare providers, underscoring a broad national footprint and a meaningful role in hospital procurement and performance optimization. ([premierinc.com](https://premierinc.com/about?utm_source=openai)) Premier’s roots lie in the consolidation of healthcare alliances and purchasing organizations built to give hospitals more bargaining power and better access to supply-chain expertise. Over time, the company evolved beyond traditional group purchasing into a broader healthcare solutions platform. Its business model combines group purchasing organization services, supply-chain optimization, data and analytics, consulting, and clinical decision support tools. The company’s stated mission is to transform healthcare by helping providers improve quality while managing costs, a positioning that resonates with large hospital systems facing inflationary purchasing pressures, labor constraints, and the need for better evidence-based decision-making. ([premierinc.com](https://premierinc.com/about/why-premier?utm_source=openai)) Premier’s principal operating areas are Supply Chain Services and Performance Services. Supply Chain Services includes sourcing, contract administration, digital supply-chain solutions, and co-management programs that support provider and supplier relationships. Performance Services includes analytics, consulting, and software-enabled clinical support capabilities. Premier has also continued to invest in its technology stack; in 2025 it acquired IllumiCare to expand clinical decision support capabilities, with the acquired solution being marketed under the Stanson Health brand. That move reinforced Premier’s strategy of combining procurement scale with software and data tools rather than relying solely on a membership-driven GPO model. ([investors.premierinc.com](https://investors.premierinc.com/news/news-details/2025/Premier-Inc--Expands-Clinical-Decision-Support-CDS-Capabilities-with-Acquisition-of-IllumiCare/default.aspx?utm_source=openai)) The company has a long-standing position in U.S. healthcare supply chain management, with relationships spanning hospitals, health systems, manufacturers, and distributors. Recent commercial activity also shows that Premier continues to use its platform to secure critical products and expand into ambulatory and specialty-care channels. In 2025, Premier launched a $200 million accelerated share repurchase program, then later announced a definitive agreement to be acquired by Patient Square Capital for $2.6 billion; the transaction was completed in November 2025. In May 2026, Premier also announced Emad Rizk, M.D. as CEO, President, and Chairman. For investors, this creates a profile of a U.S.-listed healthcare services and technology platform whose near-term narrative has been shaped by strategic actions, M&A, and a transition away from the public-market setup. ([investors.premierinc.com](https://investors.premierinc.com/news/news-details/2025/Premier-Inc.-Enters-Into-200-Million-Accelerated-Share-Repurchase-Program/default.aspx?utm_source=openai))